Raisio Diagnostics Ltd, a prominent player in the diagnostics industry, is headquartered in Finland (FI) and operates extensively across Europe. Founded in the early 2000s, the company has established itself as a leader in innovative diagnostic solutions, particularly in the fields of microbiology and infectious diseases. Raisio Diagnostics is renowned for its unique range of products, including advanced testing kits and laboratory services that streamline the detection of pathogens. Their commitment to quality and accuracy has positioned them as a trusted partner for healthcare providers and laboratories. With a strong market presence and a reputation for excellence, Raisio Diagnostics continues to achieve significant milestones, contributing to advancements in public health and safety. Their focus on research and development ensures they remain at the forefront of the diagnostics sector, meeting the evolving needs of the healthcare industry.
How does Raisio Diagnostics Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Raisio Diagnostics Ltd's score of 43 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Raisio Diagnostics Ltd, headquartered in Finland (FI), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Merck KGaA, which influences its climate commitments and targets. Raisio Diagnostics Ltd's climate initiatives are aligned with those of its parent company, Merck KGaA, which has established science-based targets (SBTi) and participates in the Carbon Disclosure Project (CDP). These initiatives are cascaded down from Merck KGaA, reflecting a commitment to reducing carbon emissions across its operations. While specific reduction targets for Raisio Diagnostics Ltd are not detailed, the overarching goals set by Merck KGaA aim to enhance sustainability and reduce environmental impact. As a part of the corporate family, Raisio Diagnostics Ltd is expected to contribute to these broader climate objectives, although specific metrics and achievements at the subsidiary level remain unspecified. In summary, while Raisio Diagnostics Ltd does not provide direct emissions data or specific reduction targets, it is positioned within a framework of climate commitments established by its parent company, Merck KGaA, which is focused on sustainability and emission reductions.
Access structured emissions data, company-specific emission factors, and source documents
2006 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 352,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | - | 000,000,000 |
Scope 2 | 402,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | 000,000,000 |
Scope 3 | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Raisio Diagnostics Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.